口臭藥物市場（按成分、產品類型、疾病類型和分銷管道）—2025-2030 年全球預測

2024 年口臭藥物市值為 39.1 億美元，預計 2025 年將達到 41.8 億美元，複合年成長率為 7.07%，到 2030 年將達到 59 億美元。

主要市場統計數據
基準年2024年	39.1億美元
預計2025年	41.8億美元
預測年份 2030	59億美元
複合年成長率（%）	7.07%

透過先進的解決方案、科學創新和多方面的治療，探索解決持續性口臭的複雜挑戰和新方法

口臭，俗稱口臭，影響全球相當一部分人口，並且一直是消費者和口腔健康專業人士關注的焦點。口臭的多重因素歸因於口腔內複雜的微生物生態系統，揮發性含硫化合物和其他致臭物質在此產生。分析化學的最新進展使得對這些化合物的鑑定更加精確，揭示了厭氧菌在產生最強烈、最持久的惡臭方面所起的作用。此外，患者對口臭的心理和社會反應往往與自我認知和臨床評估之間存在差異，這進一步加劇了問題的複雜性，並推動了對更可靠診斷工具的需求。

技術進步、監管環境的變化以及消費行為的轉變正在創造一場革命性的運動，重新定義口臭治療的模式

過去十年，在生物技術突破和消費者對天然個人化解決方案日益成長的需求的推動下，口臭治療生態系統發生了翻天覆地的變化。肽基抗菌劑和奈米載體遞送系統的技術進步使得精準靶向致臭細菌成為可能，從而研發出功效更高、療效更持久的製劑。同時，人工智慧和機器學習的加速應用增強了微生物組組成的預測模型，使研究人員能夠識別高風險族群並相應地制定干涉措施。

評估2025年美國關稅調整對口腔衛生產品供應鏈、分銷網路和成本結構的深遠影響

2025年即將生效的新關稅措施的宣布，為全球口氣清新成分供應鏈帶來了不確定性。活性成分（尤其是來自主要國際供應商的原料）進口關稅的變化，預計將影響原料成本和籌資策略。依賴氯化十六烷基吡啶、三氯生和鋅鹽等化合物的製造商可能需要重新審視其供應商契約，或在貿易條件更為優惠的國家或地區尋找其他採購管道。這種結構調整不僅會影響成本結構，還會影響生產計劃，因為前置作業時間會因物流限制而改變。

揭示成分、產品類型、疾病類型和分銷管道的關鍵市場細分洞察，以指導策略決策

細緻入微地了解市場區隔對於制定產品系列和行銷策略至關重要。化學活性劑繼續主導成分討論，例如因其廣泛抗菌特性而廣受認可的氯化十六烷基吡啶；因其強效抑菌而備受推崇的洛赫西定定；歷史上曾用於各種口腔清潔用品配方的三氯生；以及因其氣味結合能力而備受推崇的鋅鹽。同時，隨著消費者尋求更清潔的標籤和植物益處，對精油和植物抽取物等天然替代品的需求正在激增。產品細分揭示了快速起效的配方（如用於隨時隨地清新口氣的口氣噴霧和口香糖）與針對日常生活習慣的長效護理（如漱口水、含漱液、片劑、含片和傳統牙膏）之間的動態平衡。

解讀美洲、歐洲、中東和非洲以及亞太地區呼吸管理趨勢的區域差異，以指導有針對性的成長策略

隨著相關人員根據不同的消費行為、監管環境和經濟狀況調整策略，區域動態正在塑造全球口臭市場。在美洲，成熟的口腔護理習慣和較高的可支配收入推動了對高階配方的需求，北美消費者尤其容易接受創新的給藥系統和經臨床檢驗的產品標籤。拉丁美洲市場的特點是健康意識不斷增強，零售通路不斷拓展，這為中階市場品牌提供了抓住新需求的機會。

分析產業領導者、策略聯盟和創新軌跡，塑造口臭解決方案領域的競爭格局

市場領導正大力投資研發和策略聯盟，以保持競爭優勢。現有的化學成分製造商正在與生物技術公司合作，開發新一代抗菌劑，以針對特定的口臭病原體，同時維持有益的口腔微生物群。同時，天然萃取物專家正與學術機構成立合資企業，透過嚴格的臨床試驗檢驗精油和植物衍生物的功效，從而提升消費者信心和監管認可度。

為行業領導者提供策略藍圖，以利用不斷發展的口臭治療領域的新機會並降低風險

要在這種快節奏的環境中取得成功，產業領導者必須實施多管齊下的成長策略，在創新、營運韌性和消費者參與度之間取得平衡。首先，優先投資先進的製劑技術，例如微膠囊技術和緩釋系統，可以最大限度地減少給藥頻率，同時保持新鮮度，從而提升競爭力。此外，透過區域分佈的生產設施來提高供應鏈的靈活性，可以緩衝關稅相關的波動，確保產品供應充足和成本穩定。

我們綜合的調查方法結合了質性訪談、量化資料分析和多源三角測量，以提供可靠的見解

本報告採用嚴謹的混合方法，旨在提供可靠且可操作的洞察。主要研究包括對關鍵意見領袖（包括牙科保健專業人士、配方科學家和供應鏈專家）進行深入訪談，以捕捉關於新興趨勢、臨床療效基準和商業性創新的細微觀點。這些定性資料與廣泛的定量資料分析相輔相成，涵蓋歷史市場績效指標、成分利用率和電商銷售趨勢。透過整合不同的資料點，該研究確定了整個口臭治療生態系統的共同模式和潛在曲折點。

綜合主要研究結果與未來展望，闡明口臭管理領域的創新與市場成長途徑

綜上所述，本研究結果表明，口臭治療領域正處於曲折點，這得益於科學突破、監管要求的不斷變化以及消費者偏好的不斷演變。化學和天然活性成分各自提供獨特的價值提案，而新的遞送技術則兼具功效和便利性。美國即將進行的關稅調整凸顯了供應鏈彈性的重要性，而美洲、中東和非洲以及亞太地區的區域差異則凸顯了製定針對特定市場的策略的必要性。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

• 旨在恢復健康口腔微生物群的益生菌漱口水的需求日益成長
• 利用人工智慧診斷解決慢性口臭問題的個人化口腔清潔用品方案正在成長
• 消費者健康趨勢日益成長，推動口氣清新劑轉向使用天然植物萃取物
• 漱口水產品現採用環保包裝和可再填充形式，以減少塑膠廢棄物
• 整合智慧感測器的牙刷，用於即時呼吸監測和回饋
• 擴大訂閱制的直接面對消費者的口臭解決方案，推出精選口腔清潔用品套件
• 口腔護理品牌與牙科專業人士加強合作，提供經臨床檢驗的對抗口臭的解決方案
• 加速集美白、緩解牙齒敏感和控制口臭於一體的多功能牙膏的創新

第6章 市場洞察

• 波特五力分析
• PESTEL分析

第7章 2025年美國關稅的累積影響

第8章 口氣清新劑市場（依成分）

• 化學品
  • 氯化十六烷基吡啶
  • 洛赫西定
  • 三氯生
  • 鋅鹽
• 自然的
  • 精油
  • 植物萃取物

第9章 口氣清新劑市場（依產品）

• 口氣清新噴霧
• 口香糖
• 漱口水/漱口水
• 片劑/錠劑
• 牙膏

第10章 口臭藥物市場（依疾病類型）

• 真正的口臭
  • 病理性口臭
  • 生理性口臭
• 恐懼症
• 假口臭

第 11 章。口氣清新劑市場（依分銷管道）

• 離線
  • 百貨公司
  • 藥局
  • 超級市場
• 線上
  • 品牌網站
  • 電商平台

第 12 章：美洲口氣清新劑市場

• 美國
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

第 13 章：歐洲、中東和非洲的口氣清新劑市場

• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 阿拉伯聯合大公國
• 沙烏地阿拉伯
• 南非
• 丹麥
• 荷蘭
• 卡達
• 芬蘭
• 瑞典
• 奈及利亞
• 埃及
• 土耳其
• 以色列
• 挪威
• 波蘭
• 瑞士

第 14 章：亞太地區口氣清新劑市場

• 中國
• 印度
• 日本
• 澳洲
• 韓國
• 印尼
• 泰國
• 菲律賓
• 馬來西亞
• 新加坡
• 越南
• 台灣

第15章競爭格局

• 2024年市場佔有率分析
• 2024年FPNV定位矩陣
• 競爭分析
  • Chattem, Inc.
  • Church & Dwight Co., Inc.
  • Colgate-Palmolive Company
  • Dabur India Limited
  • Dentaid SL
  • Dental Herb Company
  • Dr. Harold Katz, LLC
  • GlaxoSmithKline PLC
  • Hello Products LLC
  • Johnson & Johnson
  • Kao Corporation
  • Kerr Corporation
  • Koninklijke Philips NV
  • Lion Corporation
  • OraLabs, Inc.
  • Patanjali Ayurved Ltd.
  • PerioSciences
  • Procter & Gamble Co.
  • Rowpar Pharmaceuticals, Inc
  • Sunstar Suisse SA
  • Tom's of Maine, Inc.
  • Unilever PLC
  • Viatris Inc.
  • Zendium
  • Zila, Inc.

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

The Halitosis Agent Market was valued at USD 3.91 billion in 2024 and is projected to grow to USD 4.18 billion in 2025, with a CAGR of 7.07%, reaching USD 5.90 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 3.91 billion
Estimated Year [2025]	USD 4.18 billion
Forecast Year [2030]	USD 5.90 billion
CAGR (%)	7.07%

Exploring the Complex Challenges and Emerging Approaches in Addressing Persistent Halitosis Through Advanced Solutions, Scientific Innovations, and Multidimensional Therapies

Breath malodor, typically known as halitosis, affects a substantial segment of the global population and remains a persistent concern for both consumers and oral health professionals. The multifactorial nature of this condition stems from complex microbial ecosystems within the oral cavity where volatile sulfur compounds and other malodorous byproducts are generated. Recent advances in analytical chemistry have enabled more precise identification of these compounds, illuminating the role of anaerobic bacteria in producing the most potent and persistent odors. Moreover, patient psycho-social responses to halitosis create an additional layer of complexity as self-perception often diverges from clinical assessments, driving demand for more reliable diagnostic tools.

In response to these challenges, cross-disciplinary research has accelerated the exploration of novel therapeutic modalities. Innovations range from microbiome-targeted formulations that selectively inhibit pathogenic strains to advanced delivery systems engineered to provide sustained release of active ingredients. Furthermore, integration of digital health platforms is empowering both practitioners and consumers with real-time tracking of breath quality through smartphone-enabled sensors. As regulatory landscapes evolve to encompass these cutting-edge solutions, stakeholders are increasingly focused on establishing standardized efficacy benchmarks. In this dynamic environment, a comprehensive understanding of both the underlying science and emerging product innovations is essential for guiding strategic investment and fostering improved patient outcomes.

Revolutionary Dynamics Redefining the Halitosis Treatment Landscape Fueled by Technological Advancements, Regulatory Changes, and Consumer Behavior Shifts

Over the past decade, the halitosis treatment ecosystem has undergone transformative shifts driven by breakthroughs in biotechnology and heightened consumer demand for natural and personalized solutions. Technological advancements in peptide-based antimicrobials and nanocarrier delivery systems have enabled precise targeting of malodor-causing bacteria, ushering in formulations with greater efficacy and longer-lasting effects. Simultaneously, accelerated adoption of artificial intelligence and machine learning has enhanced predictive modeling for microbiome composition, allowing researchers to identify at-risk populations and tailor interventions accordingly.

Regulatory frameworks have also evolved to address the complexity of oral care products that claim both therapeutic and cosmetic benefits. Agencies now require more robust clinical evidence to substantiate efficacy claims, prompting manufacturers to undertake rigorous randomized controlled trials and longitudinal studies. Moreover, heightened consumer awareness of ingredient transparency has shifted purchasing decisions toward formulations emphasizing naturally derived extracts and plant-based actives. Online platforms and social media influencers are further amplifying these trends, empowering end users to research ingredient profiles and brand reputations before making informed choices. Together, these technological, regulatory, and consumer-driven forces are redefining competitive dynamics, compelling stakeholders to innovate rapidly and reimagine traditional halitosis management paradigms

Assessing the Far-Reaching Consequences of United States 2025 Tariff Adjustments on Halitosis Prevention Supply Chains, Distribution Networks, and Cost Structures

The announcement of new tariff measures set to take effect in 2025 has introduced an element of uncertainty across global supply chains for halitosis treatment components. Changes in import duties on active ingredients, particularly those sourced from key international suppliers, are expected to influence raw material costs and procurement strategies. Manufacturers that rely on chemical compounds such as cetylpyridinium chloride, triclosan, and zinc salts may need to reevaluate supplier agreements or seek alternative sourcing options in jurisdictions with more favorable trade terms. This realignment has implications not only for cost structures but also for production timelines as lead times shift in response to logistical constraints.

In parallel, distribution networks are adapting to these tariff-driven pressures by optimizing inventory management and exploring nearshoring opportunities to mitigate the impact of fluctuating duties. Organizations with diversified manufacturing footprints are poised to leverage regional facilities to maintain supply continuity and stabilize margins. Retail channels, both brick-and-mortar and digital, are closely monitoring these developments to anticipate changes in retail pricing and consumer demand elasticity. Forward-looking companies are already engaging in scenario planning, assessing the interplay between tariff trajectories, currency fluctuations, and macroeconomic indicators. Through proactive risk assessment and supply chain resiliency measures, industry participants aim to minimize disruptions and preserve the affordability of halitosis management solutions for end users.

Unveiling Critical Market Segmentation Insights Across Components, Products, Disease Types, and Distribution Channels to Guide Strategic Decisions

A nuanced understanding of market segmentation is fundamental for tailoring product portfolios and marketing strategies. Chemical actives continue to dominate component discussions, with cetylpyridinium chloride recognized for its broad-spectrum antimicrobial properties, chlorhexidine valued for its potent bacterial inhibition, triclosan historically employed in diverse oral care formulations, and zinc salts acclaimed for their odor-binding capabilities. Meanwhile, demand for natural alternatives such as essential oils and plant extracts has surged as consumers seek cleaner labels and botanical efficacy. Product segmentation reveals a dynamic equilibrium between immediate delivery formats like breath sprays and chewing gums, which cater to on-the-go freshness, and more sustained treatments including mouthwashes, rinses, tablets, lozenges, and traditional toothpastes designed for daily routines.

Disease type further informs product development as genuine halitosis, encompassing both pathologic and physiologic origins, necessitates clinically proven actives, whereas halitophobia and pseudo-halitosis often require adjunctive psychological support and diagnostic clarity. Distribution channel insights underscore the continued relevance of offline retail through department stores, pharmacy outlets, and supermarkets, while online avenues via brand-owned websites and large-scale e-commerce platforms are rapidly expanding their footprint. This segmentation framework illuminates consumer preferences, guides targeted messaging across diverse channels, and enables stakeholders to align R&D investments with the most promising market niches.

Deciphering Regional Variations in Halitosis Management Trends Across the Americas, Europe Middle East & Africa, and Asia Pacific for Targeted Growth Strategies

Regional dynamics are shaping the global halitosis market as stakeholders adapt strategies to diverse consumer behaviors, regulatory landscapes, and economic conditions. In the Americas, established oral care habits and high disposable incomes drive demand for premium formulations, with North American consumers particularly receptive to innovative delivery systems and clinically validated product claims. Latin American markets are characterized by rising health awareness and growing access to retail channels, offering opportunities for mid-tier brands to capture emerging demand.

Across Europe, the Middle East, and Africa, heterogeneous regulatory frameworks challenge manufacturers to navigate varying approval processes, ingredient restrictions, and labeling requirements. Western European markets emphasize sustainability and natural ingredients, prompting increased investment in plant-based actives. Meanwhile, Gulf Cooperation Council countries demonstrate rapid adoption of online retail for oral care, while African markets prioritize cost-effective solutions due to budget constraints, leading to niche growth for affordable, high-efficacy formulations.

In the Asia Pacific region, cultural practices and traditional medicinal systems influence consumer preferences, with ingredients derived from herbal remedies gaining traction. Rapid urbanization and digital penetration are accelerating e-commerce sales in key markets such as China and India, while Japan and Australia continue to showcase mature markets with rigorous quality standards. These regional insights not only highlight distinct growth drivers but also underscore the need for customized approaches to product formulation, pricing, and distribution to maximize impact in each geography.

Analyzing Leading Industry Players, Strategic Collaborations, and Innovation Trajectories Shaping the Competitive Landscape in Halitosis Solutions Domain

Market leaders are investing heavily in research partnerships and strategic alliances to maintain competitive advantage. Established chemical ingredient manufacturers are collaborating with biotech firms to develop next-generation antimicrobials that target specific halitosis-causing pathogens while preserving the beneficial oral microbiome. Concurrently, natural extract specialists are forming joint ventures with academic institutions to validate the efficacy of essential oils and plant derivatives through rigorous clinical trials, thereby elevating consumer confidence and regulatory acceptance.

Competitive intelligence reveals that several top-tier oral care brands are expanding their portfolios through acquisitions of niche players specializing in breath freshening technologies and oral diagnostic tools. This consolidation trend facilitates rapid integration of novel delivery platforms into mainstream product lines, enabling a seamless transition from laboratory research to mass-market distribution. Companies are also leveraging digital health platforms to offer personalized breath monitoring subscriptions and mobile applications that track long-term user adherence and outcomes. Through these multidimensional strategies, organizations are not only reinforcing existing market positions but also creating new value propositions that resonate with both consumers and healthcare professionals.

In parallel, agile startups are disrupting traditional value chains by introducing direct-to-consumer models that emphasize transparency, subscription-based replenishment, and community-driven feedback loops. Their ability to iterate quickly on product formulations and marketing messages is reshaping consumer expectations and encouraging legacy brands to adopt more consumer-centric innovation frameworks.

Strategic Roadmap for Industry Leaders to Capitalize on Emerging Opportunities and Mitigate Risks in the Evolving Halitosis Treatment Sector

To thrive in this fast-paced environment, industry leaders must implement a multi-pronged growth strategy that balances innovation, operational resilience, and consumer engagement. First, prioritizing investment in advanced formulation technologies such as microencapsulation and time-release systems will provide a competitive edge by delivering sustained freshness while minimizing dosing frequency. Additionally, enhancing supply chain agility through regionally diversified manufacturing facilities can buffer against tariff-related volatility, ensuring product availability and stable costing.

Moreover, integrating digital tools into the customer journey-ranging from mobile breath analysis apps to virtual dental consultations-will strengthen brand loyalty and generate valuable user data for ongoing product optimization. Collaborative research initiatives with academic and clinical partners should be pursued to validate claims and expedite regulatory approvals, particularly for novel actives and natural ingredients. From a marketing perspective, targeted communication that addresses specific consumer segments-whether those seeking immediate freshness solutions or clinical-grade treatment for genuine halitosis-will resonate more effectively when aligned with insights derived from component, product, disease type, and channel analysis.

Finally, sustainability commitments around eco-friendly packaging and responsibly sourced ingredients will not only meet evolving regulatory standards but also appeal to the growing cohort of environmentally conscious consumers. By holistically addressing innovation, supply chain resilience, digital integration, and sustainability, industry leaders can confidently navigate the complexities of the halitosis solutions market and secure long-term growth.

Comprehensive Research Methodology Combining Qualitative Interviews, Quantitative Data Analysis, and Multisource Triangulation to Ensure Robust Insights

This report draws upon a rigorous mixed-methods approach to deliver credible and actionable insights. Primary research involved in-depth interviews with key opinion leaders, including dental professionals, formulation scientists, and supply chain experts, to capture nuanced perspectives on emerging trends, clinical efficacy benchmarks, and commercial innovations. These qualitative inputs were supplemented by extensive quantitative data analysis, which encompassed historical market performance metrics, ingredient utilization rates, and e-commerce sales trajectories. By harmonizing diverse data points, the study identifies prevailing patterns and potential inflection points across the halitosis treatment ecosystem.

Secondary research included systematic reviews of peer-reviewed journals, patent filings, and regulatory filings to track technological advancements and compliance requirements. Additionally, corporate disclosures and investor presentations provided visibility into strategic initiatives, investment flows, and partnership announcements. To enhance reliability, findings from primary and secondary sources underwent rigorous triangulation, wherein inconsistencies were examined and reconciled through follow-up consultations with domain experts. Regional case studies further enriched the analysis by illustrating how macroeconomic factors and cultural preferences shape adoption rates in the Americas, Europe Middle East & Africa, and Asia Pacific.

This comprehensive methodology ensures that the insights presented are grounded in empirical evidence and industry expertise, enabling stakeholders to make informed strategic decisions with confidence.

Synthesizing Key Findings and Forward-Looking Perspectives to Illuminate the Path Ahead for Halitosis Management Innovation and Market Growth

In synthesizing the insights uncovered through this study, it is clear that the halitosis treatment landscape is at an inflection point driven by scientific breakthroughs, shifting regulatory requirements, and evolving consumer preferences. Chemical and natural actives each offer distinct value propositions, and emerging delivery technologies promise to reconcile efficacy with convenience. The looming tariff adjustments in the United States underscore the importance of supply chain versatility, while regional nuances across the Americas, Europe Middle East & Africa, and Asia Pacific highlight the need for market-specific strategies.

Industry participants are increasingly leveraging strategic alliances, digital health integration, and sustainability commitments to differentiate their offerings and strengthen stakeholder trust. Moreover, the granularity provided by component, product, disease type, and channel segmentation lays the groundwork for highly targeted innovation roadmaps and marketing campaigns. As competitive dynamics intensify, success will hinge on an organization's ability to seamlessly align research and development with consumer insights, regulatory expectations, and operational resilience.

Looking forward, continued investment in microbiome research, clinical validation, and personalized solutions will be pivotal in unlocking new growth avenues. By embracing a holistic approach that integrates science, technology, and consumer-centricity, stakeholders can drive meaningful improvements in oral health while capturing significant market opportunities.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Rising demand for probiotic-infused mouth rinses aimed at restoring healthy oral microbiome balance
• 5.2. Growth of personalized oral care regimens leveraging AI diagnostics to address chronic bad breath complaints
• 5.3. Shift towards natural botanical extracts in halitosis formulations driven by consumer wellness trends
• 5.4. Adoption of eco-friendly packaging and refillable formats in mouthwash products to reduce plastic waste
• 5.5. Integration of smart sensor-enabled toothbrushes providing real-time halitosis monitoring and feedback
• 5.6. Expansion of subscription-based direct-to-consumer halitosis solutions featuring curated oral health kits
• 5.7. Increasing collaboration between oral care brands and dental professionals for clinically validated breath solutions
• 5.8. Accelerated innovation in multifunctional toothpaste combining whitening sensitivity relief and breath control

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Halitosis Agent Market, by Component

• 8.1. Introduction
• 8.2. Chemical
  • 8.2.1. Cetylpyridinium Chloride
  • 8.2.2. Chlorhexidine
  • 8.2.3. Triclosan
  • 8.2.4. Zinc Salts
• 8.3. Natural
  • 8.3.1. Essential Oils
  • 8.3.2. Plant Extracts

9. Halitosis Agent Market, by Product

• 9.1. Introduction
• 9.2. Breath Sprays
• 9.3. Chewing Gums
• 9.4. Mouthwashes/Rinses
• 9.5. Tablets/Lozenges
• 9.6. Toothpastes

10. Halitosis Agent Market, by Disease Type

• 10.1. Introduction
• 10.2. Genuine Halitosis
  • 10.2.1. Pathologic Halitosis
  • 10.2.2. Physiologic Halitosis
• 10.3. Halitophobia
• 10.4. Pseudo-Halitosis

11. Halitosis Agent Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Offline
  • 11.2.1. Department Stores
  • 11.2.2. Pharmacy Stores
  • 11.2.3. Supermarkets
• 11.3. Online
  • 11.3.1. Brand Websites
  • 11.3.2. E-commerce Platforms

12. Americas Halitosis Agent Market

• 12.1. Introduction
• 12.2. United States
• 12.3. Canada
• 12.4. Mexico
• 12.5. Brazil
• 12.6. Argentina

13. Europe, Middle East & Africa Halitosis Agent Market

• 13.1. Introduction
• 13.2. United Kingdom
• 13.3. Germany
• 13.4. France
• 13.5. Russia
• 13.6. Italy
• 13.7. Spain
• 13.8. United Arab Emirates
• 13.9. Saudi Arabia
• 13.10. South Africa
• 13.11. Denmark
• 13.12. Netherlands
• 13.13. Qatar
• 13.14. Finland
• 13.15. Sweden
• 13.16. Nigeria
• 13.17. Egypt
• 13.18. Turkey
• 13.19. Israel
• 13.20. Norway
• 13.21. Poland
• 13.22. Switzerland

14. Asia-Pacific Halitosis Agent Market

• 14.1. Introduction
• 14.2. China
• 14.3. India
• 14.4. Japan
• 14.5. Australia
• 14.6. South Korea
• 14.7. Indonesia
• 14.8. Thailand
• 14.9. Philippines
• 14.10. Malaysia
• 14.11. Singapore
• 14.12. Vietnam
• 14.13. Taiwan

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Chattem, Inc.
  • 15.3.2. Church & Dwight Co., Inc.
  • 15.3.3. Colgate-Palmolive Company
  • 15.3.4. Dabur India Limited
  • 15.3.5. Dentaid S.L.
  • 15.3.6. Dental Herb Company
  • 15.3.7. Dr. Harold Katz, LLC
  • 15.3.8. GlaxoSmithKline PLC
  • 15.3.9. Hello Products LLC
  • 15.3.10. Johnson & Johnson
  • 15.3.11. Kao Corporation
  • 15.3.12. Kerr Corporation
  • 15.3.13. Koninklijke Philips N.V.
  • 15.3.14. Lion Corporation
  • 15.3.15. OraLabs, Inc.
  • 15.3.16. Patanjali Ayurved Ltd.
  • 15.3.17. PerioSciences
  • 15.3.18. Procter & Gamble Co.
  • 15.3.19. Rowpar Pharmaceuticals, Inc
  • 15.3.20. Sunstar Suisse S.A.
  • 15.3.21. Tom's of Maine, Inc.
  • 15.3.22. Unilever PLC
  • 15.3.23. Viatris Inc.
  • 15.3.24. Zendium
  • 15.3.25. Zila, Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix